At a glance
- Originator Ikena Oncology
- Class Antineoplastics; Imidazoles; Small molecules; Sulfonamides
- Mechanism of Action TEA domain transcription factors inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Cancer; Non-small cell lung cancer; Solid tumours